Results 121 to 130 of about 81,908 (215)

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions? [PDF]

Am J Psychiatry
Levinstein MR, Budinich RC, Bonaventura J, Schatzberg AF, Zarate CA, Michaelides M.   +5 more
europepmc   +1 more source

Childhood family environment and μ-opioid receptor availability in vivo in adulthood. [PDF]

Neuropsychopharmacology
Saarinen A, Tuominen L, Puttonen S, Raitakari O, Keltikangas-Järvinen L, Hietala J.   +5 more
europepmc   +1 more source

Characterization of δ, κ, and μ Human Opioid Receptors Overexpressed in Baculovirus-infected Insect Cells [PDF]

, 1997
Dominique Massotte, Laurence Baroche, Frédéric Simonin, Lei Yu, Brigitte L. Kieffer, Franc Pattus   +5 more
openalex   +1 more source

Effects of social isolation on locus coeruleus opioid receptor expression and affective behavior. [PDF]

Neurobiol Stress
Tkaczynski J, Riser J, Patel M, Shellenbarger N, Park J, Manvich D, Chandler DJ.   +6 more
europepmc   +1 more source

Lesioning of the nucleus basalis of Meynert has differential effects on mu, delta and kappa opioid receptor binding in rat brain: a quantitative autoradiographic study

, 1992
Danielle Ofri, Li-Qun Fan, Eric J. Simon, Jacob M. Hiller   +3 more
openalex   +1 more source

Biased Opioid Receptor Agonists: Balancing Analgesic Efficacy and Side-Effect Profiles. [PDF]

Int J Mol Sci
Ju J, Li Z, Liu J, Peng X, Gao F.
europepmc   +1 more source

Effects of a kappa opioid receptor antagonist on delayed postoperative pain recovery in a novel mouse sleep disorder model. [PDF]

Front Pain Res (Lausanne)
Ito H, Kawakami M, Yoshida M, Sugimoto S, Takazawa T.   +4 more
europepmc   +1 more source

Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone. [PDF]

Arch Toxicol
Endt F, Guo T, Steinritz D, Amend N, Gudermann T, Breit A.   +5 more
europepmc   +1 more source

Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling. [PDF]

PLoS Pathog
Audibert A, Mas-Orea X, Rey L, Belloy M, Bassot E, Battut L, Marodon G, Masson F, Serino M, Cenac N, Dietrich G, Bonnart C, Blanchard N.   +12 more
europepmc   +1 more source

A new pathway for neuroprotection against tau hyperphosphorylation via δ-opioid receptor initiated inhibition of CDK5 and AMPK signaling. [PDF]

Front Aging Neurosci
Li J, Xu Y, Balboni G, Xia Y.
europepmc   +1 more source